Filing Flows › Chemours (CC) › R&D spending
Chemours (CC) R&D spending by quarter
Chemours' R&D spending was $26.0M in Q1 2026 (first quarter 2026), -4% from Q4 2025. Over the last 5 quarters it ranged from $26.0M (Q1 2026) to $28.0M (Q2 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q1 2026 | $26.0M | -4% | -4% |
| Q4 2025 | $27.0M | +4% | — |
| Q3 2025 | $26.0M | -7% | — |
| Q2 2025 | $28.0M | +4% | — |
| Q1 2025 | $27.0M | — | — |
Q1 2026 at a glance
Chemours, Q1 2026: revenue $1.4B (+1% year over year), operating margin -1.6%, net loss $29.0M, operating cash flow −$44.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Chemours' R&D spending?
Chemours' R&D spending was $26.0M in Q1 2026 (first quarter 2026), -4% from Q4 2025.
How has Chemours' R&D spending changed?
Over the last 5 quarters it ranged from $26.0M (Q1 2026) to $28.0M (Q2 2025).